Boston Common Asset Management, LLC Illumina, Inc. Transaction History

Boston Common Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$187.24 - $242.74 $2,808 - $3,641	15 Added 0.05%	32,294 $6.53 Million
Q3 2022 Oct 20, 2022	SELL	$177.23 - $227.44 $1.56 Million - $2 Million	-8,805 Reduced 21.43%	32,279 $6.16 Million
Q2 2022 Aug 10, 2022	BUY	$181.58 - $368.0 $467,386 - $947,232	2,574 Added 6.68%	41,084 $7.57 Million
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $66,547 - $92,812	219 Added 0.57%	38,510 $13.5 Million
Q4 2021 Jan 31, 2022	BUY	$347.28 - $421.83 $56,606 - $68,758	163 Added 0.43%	38,291 $14.6 Million
Q3 2021 Nov 12, 2021	SELL	$405.61 - $524.84 $534,593 - $691,739	-1,318 Reduced 3.34%	38,128 $15.5 Million
Q2 2021 Aug 19, 2021	BUY	$372.84 - $481.5 $14.7 Million - $19 Million	39,446 New	39,446 $18.7 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boston Common Asset Management, LLC with notifications on news.